Vaccination News

Two randomized, placebo-controlled trials of three Ebola vaccine regimens demonstrated that they are safe and spur lasting antibodies in both children and adults, according to findings reported in The New England Journal of Medicine.

CDC researchers published a resource for providers that outlines the epidemiology and clinical features of mpox in children and adolescents and how it can be diagnosed and managed.

After a sharp increase in global malaria cases and deaths as COVID-19 spread in 2020, WHO reported that both cases and deaths remained relatively stable in 2021.

Pfizer recently announced that its respiratory syncytial vaccine candidate for older adults, RSVpreF, was granted priority review by the FDA.

The odds for developing new postural orthostatic tachycardia syndrome within 90 days after COVID-19 vaccination were more than five times lower compared with likelihood after SARS-CoV-2 infection, researchers reported.

The incidence of myopericarditis among adolescents and young adults who received mRNA COVID-19 vaccines is very low, according to a systemic review and meta-analysis published in JAMA Pediatrics.

The FDA on Thursday expanded its emergency use authorization of Moderna and Pfizer-BioNTech’s omicron-targeting bivalent COVID-19 boosters to include children aged as young as 6 months in the United States.

An expert in influenza is encouraging the public to get vaccinated ahead of “a tough season” during National Influenza Vaccination Week.

A nationally representative study demonstrated a wide geographic variation in influenza vaccination for both non-Hispanic white and Hispanic short-stay and long-stay nursing home residents.

Pfizer and BioNTech are seeking an emergency use authorization from the FDA for omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.